In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

ESC Working Group on Cardiovascular Pharmacotherapy

The Working Group on Cardiovascular Pharmacotherapy of the ESC is actively involved with all aspects of cardiovascular pharmacology, from basic pharmacology over clinical trials to clinical pharmacology.

Our Working Group was featured in the November 2023 edition of CardioPulse in the European Heart Journal. Read about the evolution of our Working Group and our endeavours to inform and educate trainees and established practitioners working in the field.

Aims and Activities

Aims

  • To promote and organise research in the field of cardiovascular pharmacology and drug therapy
  • To design and coordinate scientific research in its specialty
  • To be involved in task forces of the European Society of Cardiology related to cardiovascular pharmacology
  • To increase the number of Working Group members

Activities

  • To start up and strengthen the new journal of the Working Group, entitled European Heart Journal-Cardiovascular Pharmacotherapy. The journal will come out with 4 issues during 2015 aiming at increasing that number up to 12 issues a year within 5-6 years. An aim with the journal is to become the strongest scientific journal within cardiovascular pharmacology
  • To organise yearly scientific meeting of the Working Group with focus on cardiovascular pharmacology
  • To participate in the production of ESC Clinical Practice Guidelines
  • To publish position papers within the area of the Working Group
  • To contribute to the organisation and preparation of the Annual Congress of the ESC
  • To participate and support other scientific meetings and symposia
  • To organise teaching workshops and other types of education on topics related to cardiovascular pharmacology and drug therapy
  • To hold regular meetings of the nucleus of the Working Group

Nucleus 2024-2026

Chairperson

Dobromir Dobrev, FESC, Germany

Chairperson-Elect 

Bianca Rocca, FESC, Italy

Past-Chairperson

  Juan Carlos Kaski, FESC, UK of Great Britain and Northern Ireland

Treasurer

Giuseppe Ambrosio, FESC, Italy

Secretary & Coordinator

  William Parker, FESC, UK of Great Britain and Northern Ireland

Members

  • Claudio Borghi, FESC, Italy
  • Peter Ferdinandy, Hungary
  • Erik Lerkevang Grove, FESC, Denmark
  • Joao Morais, FESC, Portugal
  • Anne Grete Semb, FESC, Norway
  • Samuel Sossalla,  Germany
  • Patrick Sulzgruber, FESC, Austria
  • Elisabetta Cerbai*, FESC, Italy
  • Gheorghe Andrei Dan*, FESC, Romania
  • Roland Klingenberg*, FESC, Germany
  • Editor-in-Chief*:  Stefan Agewall, FESC, Sweden

*non-voting members

 
About the ESC
Press and Media
Information
Follow us

         

 Need help?

 Help centre
 Contact us

© 2024 European Society of Cardiology. All rights reserved.